UPM/Sappi: EU Doubts Behavioral Remedies Can Resolve Competition Concerns, Sources Say

The European Commission is skeptical that behavioral remedies will be enough to address competition concerns over paper giants UPM-Kymmene and Sappi’s proposed €1.42 billion ($1.59 billion) joint venture, even as the companies discuss concessions in an effort to secure approval, according to people familiar with the matter

Published on Oct 13, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.